440 related articles for article (PubMed ID: 33161039)
21. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
22. High throughput microfluidics-based synthesis of PEGylated liposomes for precise size control and efficient drug encapsulation.
Akar S; Fardindoost S; Hoorfar M
Colloids Surf B Biointerfaces; 2024 Jun; 238():113926. PubMed ID: 38677154
[TBL] [Abstract][Full Text] [Related]
23. [Preparation and Characterization of Clopidogrel Bisulfate Liposomes].
Wu BQ; He YJ; Yin ZN; Zhang ZR; Deng L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):630-636. PubMed ID: 34323042
[TBL] [Abstract][Full Text] [Related]
24. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.
Fan Y; Marioli M; Zhang K
J Pharm Biomed Anal; 2021 Jan; 192():113642. PubMed ID: 33011580
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical characterization and skin permeation of liposome formulations containing clindamycin phosphate.
Shanmugam S; Song CK; Nagayya-Sriraman S; Baskaran R; Yong CS; Choi HG; Kim DD; Woo JS; Yoo BK
Arch Pharm Res; 2009 Jul; 32(7):1067-75. PubMed ID: 19641889
[TBL] [Abstract][Full Text] [Related]
26. Rapid scale-up and production of active-loaded PEGylated liposomes.
Roces CB; Port EC; Daskalakis NN; Watts JA; Aylott JW; Halbert GW; Perrie Y
Int J Pharm; 2020 Aug; 586():119566. PubMed ID: 32622812
[TBL] [Abstract][Full Text] [Related]
27. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
28. A comparison between conventional liposome and drug-cyclodextrin complex in liposome system.
Wang WX; Feng SS; Zheng CH
Int J Pharm; 2016 Nov; 513(1-2):387-392. PubMed ID: 27640244
[TBL] [Abstract][Full Text] [Related]
29. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
30. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
Changsan N; Chan HK; Separovic F; Srichana T
J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method.
Jaradat E; Weaver E; Meziane A; Lamprou DA
Mol Pharm; 2023 Dec; 20(12):6184-6196. PubMed ID: 37931072
[TBL] [Abstract][Full Text] [Related]
32. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration.
Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN
Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806
[TBL] [Abstract][Full Text] [Related]
33. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
[TBL] [Abstract][Full Text] [Related]
34. A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment.
Xu X; Khan MA; Burgess DJ
Int J Pharm; 2011 Oct; 419(1-2):52-9. PubMed ID: 21787854
[TBL] [Abstract][Full Text] [Related]
35. Encapsulation, stability and in-vitro release characteristics of liposomal formulations of colchicine.
Kulkarni SB; Singh M; Betageri GV
J Pharm Pharmacol; 1997 May; 49(5):491-5. PubMed ID: 9178182
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of HPLC method for simultaneous estimation of erlotinib and niclosamide from liposomes optimized by screening design.
Padakanti AP; Pawar SD; Kumar P; Chella N
J Liposome Res; 2023 Sep; 33(3):268-282. PubMed ID: 36594184
[TBL] [Abstract][Full Text] [Related]
37. Research on the preparation process of the cytarabine/daunorubicin dual-encapsulation liposome and its physicochemical properties and performances in vitro/vivo.
Liu B; Zhang J; Liu Z; Wang P; Zhang Y; He H; Yin T; Gou J; Tang X
Int J Pharm; 2023 Nov; 646():123500. PubMed ID: 37820944
[TBL] [Abstract][Full Text] [Related]
38. Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN).
Zielińska A; Ferreira NR; Feliczak-Guzik A; Nowak I; Souto EB
Pharm Dev Technol; 2020 Sep; 25(7):832-844. PubMed ID: 32204628
[TBL] [Abstract][Full Text] [Related]
39. The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles.
Alinaghi A; Rouini MR; Johari Daha F; Moghimi HR
Int J Pharm; 2014 Jan; 459(1-2):30-9. PubMed ID: 24239579
[TBL] [Abstract][Full Text] [Related]
40. Optimization, characterization and evaluation of liposomes from Malus hupehensis (Pamp.) Rehd. extracts.
Guo D; Liu J; Fan Y; Cheng J; Shi Y; Zou J; Zhang X
J Liposome Res; 2020 Dec; 30(4):366-376. PubMed ID: 31387437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
